Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Pro Dex (PDEX) over the last 12 years, with Q4 2025 value amounting to $8.0 million.

  • Pro Dex's Cash & Equivalents rose 1195000.0% to $8.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $8.0 million, marking a year-over-year increase of 1195000.0%. This contributed to the annual value of $6.9 million for FY2025, which is 1881.55% up from last year.
  • As of Q4 2025, Pro Dex's Cash & Equivalents stood at $8.0 million, which was up 1195000.0% from $10.2 million recorded in Q3 2025.
  • Pro Dex's 5-year Cash & Equivalents high stood at $10.2 million for Q3 2025, and its period low was $66000.0 during Q4 2024.
  • For the 5-year period, Pro Dex's Cash & Equivalents averaged around $3.9 million, with its median value being $3.2 million (2024).
  • As far as peak fluctuations go, Pro Dex's Cash & Equivalents tumbled by 9487.98% in 2024, and later soared by 1195000.0% in 2025.
  • Over the past 5 years, Pro Dex's Cash & Equivalents (Quarter) stood at $5.3 million in 2021, then plummeted by 92.73% to $382000.0 in 2022, then skyrocketed by 237.43% to $1.3 million in 2023, then tumbled by 94.88% to $66000.0 in 2024, then skyrocketed by 11950.0% to $8.0 million in 2025.
  • Its Cash & Equivalents was $8.0 million in Q4 2025, compared to $10.2 million in Q3 2025 and $6.9 million in Q2 2025.